153 related articles for article (PubMed ID: 35195574)
1. SARS-CoV-2 Testing and Positivity Among Persons With and Without HIV in 6 US Cohorts.
Park LS; McGinnis KA; Gordon KS; Justice AC; Leyden W; Silverberg MJ; Skarbinski J; Jefferson C; Horberg M; Certa J; Napravnik S; Edwards JK; Westreich D; Bastarache L; Gangireddy S; Benning L; D'Souza G; Williams C; Althoff KN;
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):249-255. PubMed ID: 35195574
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV in the US.
Lang R; Humes E; Coburn SB; Horberg MA; Fathi LF; Watson E; Jefferson CR; Park LS; Gordon KS; Akgün KM; Justice AC; Napravnik S; Edwards JK; Browne LE; Agil DM; Silverberg MJ; Skarbinski J; Leyden WA; Stewart C; Hogan BC; Gebo KA; Marconi VC; Williams CF; Althoff KN;
JAMA Netw Open; 2022 Oct; 5(10):e2236397. PubMed ID: 36227594
[TBL] [Abstract][Full Text] [Related]
4. Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
Lea AN; Leyden WA; Sofrygin O; Marafino BJ; Skarbinski J; Napravnik S; Agil D; Augenbraun M; Benning L; Horberg MA; Jefferson C; Marconi VC; Park LS; Gordon KS; Bastarache L; Gangireddy S; Althoff KN; Coburn SB; Gebo KA; Lang R; Williams C; Silverberg MJ
Clin Infect Dis; 2023 May; 76(10):1727-1734. PubMed ID: 36861341
[TBL] [Abstract][Full Text] [Related]
5. Long-lasting adaptive immune memory specific to SARS-CoV-2 in convalescent coronavirus disease 2019 stable people with HIV.
Donadeu L; Tiraboschi JM; Scévola S; Torija A; Meneghini M; Jouve T; Favà A; Calatayud L; Ardanuy C; Cidraque I; Preyer R; Strecker K; Lozano JJ; Podzamczer D; Crespo E; Bestard O
AIDS; 2022 Aug; 36(10):1373-1382. PubMed ID: 35730384
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022.
Teran RA; Gagner A; Gretsch S; Lauritsen J; Galanto D; Walblay K; Ruestow P; Korban C; Pacilli M; Kern D; Black SR; Tabidze I
Emerg Infect Dis; 2023 Nov; 29(11):2257-2265. PubMed ID: 37877555
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 infections post-vaccination by HIV status in the United States.
Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon K; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg M; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
medRxiv; 2021 Dec; ():. PubMed ID: 34909791
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 percent positivity and risk factors among people with HIV at an urban academic medical center.
Friedman EE; Devlin SA; McNulty MC; Ridgway JP
PLoS One; 2021; 16(7):e0254994. PubMed ID: 34288954
[TBL] [Abstract][Full Text] [Related]
9. Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study.
Yendewa GA; Perez JA; Patil N; McComsey GA
Front Immunol; 2024; 15():1297195. PubMed ID: 38318191
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 testing, positivity, and factors associated with COVID-19 among people with HIV across Europe in the multinational EuroSIDA cohort.
Fursa O; Bannister W; Neesgaard B; Podlekareva D; Kowalska J; Benfield T; Gerstoft J; Reekie J; Rasmussen LD; Aho I; Guaraldi G; Staub T; Miro JM; Laporte JM; Elbirt D; Trofimova T; Sedlacek D; Matulionyte R; Oprea C; Bernasconi E; Hadžiosmanović V; Mocroft A; Peters L;
HIV Med; 2024 Jun; 25(6):711-724. PubMed ID: 38433476
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
[TBL] [Abstract][Full Text] [Related]
12. People with HIV have a higher risk of COVID-19 diagnosis but similar outcomes to the general population.
Tang ME; Gaufin T; Anson R; Zhu W; Mathews WC; Cachay ER
HIV Med; 2022 Nov; 23(10):1069-1077. PubMed ID: 35394110
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 symptoms and SARS-CoV-2 infection among people living with HIV in the US: the MACS/WIHS combined cohort study.
D'Souza G; Springer G; Gustafson D; Kassaye S; Alcaide ML; Ramirez C; Sharma A; Palella FJ; Tien PC; Detels R; Kempf MC; Lahiri CD; Rinaldo CR; French AL; Margolick JB; Adimora AA
HIV Res Clin Pract; 2020 Oct; 21(5):130-139. PubMed ID: 33211636
[TBL] [Abstract][Full Text] [Related]
14. Influenza Vaccination Uptake and Associated Factors Among Adults With and Without Human Immunodeficiency Virus in a Large, Integrated Healthcare System.
Imp BM; Levine T; Satre DD; Skarbinski J; Luu MN; Sterling SA; Silverberg MJ
Clin Infect Dis; 2023 Jul; 77(1):56-63. PubMed ID: 36857440
[TBL] [Abstract][Full Text] [Related]
15. Cognitive concerns are a risk factor for mortality in people with HIV and coronavirus disease 2019.
Wilcox DR; Rudmann EA; Ye E; Noori A; Magdamo C; Jain A; Alabsi H; Foy B; Triant VA; Robbins GK; Westover MB; Das S; Mukerji SS
AIDS; 2023 Aug; 37(10):1565-1571. PubMed ID: 37195278
[TBL] [Abstract][Full Text] [Related]
16. Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV.
Overton ET; Weir IR; Zanni MV; Fischinger S; MacArthur RD; Aberg JA; Fitch KV; Frank M; Albrecht H; Goodenough E; Rhame FS; Fichtenbaum CJ; Bloomfield GS; Malvestutto C; Supparatpinyo K; McCallum S; Douglas PS; Alter G; Ribaudo H; Grinspoon SK
J Acquir Immune Defic Syndr; 2022 Aug; 90(4):377-381. PubMed ID: 35413022
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dementia incidence and prevalence between individuals with and without HIV infection in primary care from 2000 to 2016.
Lam JO; Lee C; Gilsanz P; Hou CE; Leyden WA; Satre DD; Flamm JA; Towner WJ; Horberg MA; Silverberg MJ
AIDS; 2022 Mar; 36(3):437-445. PubMed ID: 34816805
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dementia risk after age 50 between individuals with and without HIV infection.
Lam JO; Hou CE; Hojilla JC; Anderson AN; Gilsanz P; Alexeeff SE; Levine-Hall T; Hood N; Lee C; Satre DD; Silverberg MJ
AIDS; 2021 Apr; 35(5):821-828. PubMed ID: 33394681
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.
Del Amo J; Polo R; Moreno S; Jarrín I; Hernán MA
AIDS; 2022 Feb; 36(2):161-168. PubMed ID: 34934017
[TBL] [Abstract][Full Text] [Related]
20. Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2.
Opsteen S; Fram T; Files JK; Levitan EB; Goepfert P; Erdmann N
J Acquir Immune Defic Syndr; 2024 May; 96(1):92-100. PubMed ID: 38408318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
